Laboratory News and Research

RSS

Electrical neck implants immediately restore arm mobility in stroke survivors

University of Pittsburgh School of Medicine researchers report the final outcomes of a pioneering pilot clinical trial using electrical stimulation of the spinal cord to improve arm and hand mobility in people with chronic stroke today in Nature Medicine.

4 Jun 2026

Brain remodeling bypasses the prefrontal bottleneck to automate complex skills

New research by Georgetown scientists shows how the brain rewires itself to automate learned tasks. The findings challenge a long-held understanding of how humans master complex skills, suggesting that true multitasking is really possible.

4 Jun 2026

Study potentially opens a new route to more selective cancer drug design

Researchers at the Icahn School of Medicine at Mount Sinai have identified a previously hidden druggable site in a cancer-related protein that could open the door toward the development of a new generation of more precise cancer drugs.

3 Jun 2026

New manufacturing platform produces targeted mixtures of beneficial gut bacteria

Researchers at the Icahn School of Medicine at Mount Sinai have developed a new manufacturing platform for producing targeted mixtures of beneficial gut bacteria, an approach that could help expand access to microbiome-based therapies for patients with recurrent Clostridioides difficile (C. difficile) infection.

3 Jun 2026

Scientists develop mineralized DNA hydrogel to accelerate bone repair

A new study developed a mineralized DNA hydrogel that combines immune regulation with sustained bone regeneration.

3 Jun 2026

Researchers unravel the mechanism behind precise timing of master biological clock

Imagine a train parked at the station. Passengers climb aboard and find their seats. Conductors move up and down the aisles, checking tickets.

3 Jun 2026

New antibiotic kills drug-resistant bacteria by targeting a previously unknown vulnerability

Researchers at McMaster University have discovered a new antibiotic that kills some of the world's most dangerous and drug-resistant bacteria - and does so by targeting a previously unknown vulnerability, opening the door to an entirely new class of treatments.

3 Jun 2026

Scientists mimic heart cell signaling using organic conductive plastics

For the first time, scientists have succeeded in artificially mimicking the ion signaling of heart muscle cells.

3 Jun 2026

Three-drug strategy forces pancreatic tumors into lasting regression

A triple-targeted preclinical therapy combining daraxonrasib, afatinib, and SD36 drove durable pancreatic cancer regression by blocking KRAS/RAS, EGFR/HER2, and STAT3 signaling. The approach prevented treatment resistance across mouse and human tumor-derived models, but remains preclinical and requires more clinically suitable drug combinations before human testing.

2 Jun 2026

AI turns everyday smartphone use into passive heart-rate tracking

Researchers developed Passive Heart-Rate Monitoring, a deep-learning smartphone system that estimates heart rate and daily resting heart rate from eight-second facial videos captured during normal phone use. Validated on more than 160,000 videos, the system met accuracy targets across skin-tone groups, although usable measurement rates were lower in the darkest skin-tone group and clinical use still requires further testing.

2 Jun 2026

Gladstone receives NIAID grant to establish the Center for PhAIge Therapy

When a bacterial infection stops responding to antibiotics, doctors have few options to treat it. Phages-viruses that naturally infect and kill bacteria-have long intrigued clinicians as a potential weapon against these infections.

2 Jun 2026

Existing drug mitigates muscle loss from GLP-1 medications

Millions of Americans are currently taking GLP-1 medications such as Ozempic or Wegovy for weight loss.

2 Jun 2026

New funding supports cutting-edge research to combat cancers across South Texas

The University of Texas at San Antonio (UT San Antonio) and its academic health center, UT Health San Antonio, recently received over $2.7 million in new academic and prevention awards from the Cancer Prevention and Research Institute of Texas (CPRIT) to further its mission of combating cancers across South Texas.

2 Jun 2026

New discovery provides insights into how seasonal influenza viruses infect people

Scientists investigating how influenza viruses replicate within cells "accidentally" discovered that different flu viruses use distinct strategies to infiltrate cells in the first place.

2 Jun 2026

Advancing Human Muscle Models for Drug Development and Preclinical Testing

Transforming drug development, Myomaker Bio's lab-grown muscle platforms offer human-relevant models for effective preclinical testing and risk reduction.

From Myomaker Bio 2 Jun 2026

Magnetic microrobots deliver stem cells to heal spinal cord injuries

A research team from ETH Zurich and the University of Zurich (UZH) has developed a novel approach to treating spinal cord injuries: controllable microrobots deliver stem cells directly to the site of an injury, where they promote nerve cell regeneration.

2 Jun 2026

Diagnostics start-up LotusDx establishes R&D laboratory at ONE BioHub to advance at-home STI testing

LotusDx, a medtech company developing at-home diagnostic tests for sexually transmitted infections (STIs), today announced it has established its R&D laboratory at ONE BioHub, located on the Foresterhill Health Campus, in Aberdeen.

From LotusDx 2 Jun 2026

Cellular reprogramming helps outsmart progressive Alzheimers disease

A team led by researcher José Vicente Sánchez Mut at the Institute for Neurosciences (IN), a joint center of the Spanish National Research Council (CSIC) and the Miguel Hernández University of Elche (UMH), together with researcher Johannes Gräff at the École Polytechnique Fédérale de Lausanne (EPFL), has identified an experimental molecule capable of "reprogramming" the brain's immune cells to restore part of their protective function against Alzheimer's disease.

2 Jun 2026

Whole-body PET scans track metabolic recovery after weight-loss surgery

A novel PET imaging framework reveals that bariatric surgery impacts not only body weight, but also the metabolic function of multiple organs.

1 Jun 2026

PromptSE AI predicts drug side effects by reasoning through biological clues

PromptSE uses structured LLM prompting to generate pharmacologically relevant side-effect representations, then feeds them into deep learning models to predict drug-side effect associations. In benchmark testing, PromptSE improved prediction performance, while PromptSE+ further boosted results by adding multi-modal drug information and graph-based refinement for sparse data.

1 Jun 2026